Literature DB >> 26111904

APOL1 and kidney disease: new insights leading to novel therapies.

Barry I Freedman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26111904     DOI: 10.1053/j.ajkd.2015.05.005

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

Review 1.  The Apolipoprotein L1 Gene and Cardiovascular Disease.

Authors:  Todd W Robinson; Barry I Freedman
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

2.  Concepts of Genomics in Kidney Transplantation.

Authors:  William S Oetting; Casey Dorr; Rory P Remmel; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Curr Transplant Rep       Date:  2017-05-24

3.  Stakeholder Perspectives on Returning Nonactionable Apolipoprotein L1 (APOL1) Genetic Results to African American Research Participants.

Authors:  Kathleen M West; Kerri L Cavanaugh; Erika Blacksher; Stephanie M Fullerton; Ebele M Umeukeje; Bessie Young; Wylie Burke
Journal:  J Empir Res Hum Res Ethics       Date:  2021-12-06       Impact factor: 1.978

Review 4.  At the Research-Clinical Interface: Returning Individual Genetic Results to Research Participants.

Authors:  Kathleen M West; Erika Blacksher; Kerri L Cavanaugh; Stephanie M Fullerton; Ebele M Umeukeje; Bessie A Young; Wylie Burke
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-10       Impact factor: 8.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.